Citius Pharmaceuticals (CTXR) Common Equity (2011 - 2026)
Citius Pharmaceuticals (CTXR) reported Common Equity of $75.91 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 12.4% from $67.56 million a year earlier and up 9.9% from the prior quarter.
Powered by 
Analysis
Citius Pharmaceuticals (CTXR) Common Equity (2011 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Citius Pharmaceuticals posted Common Equity of $77.53 million, up 4.6% from FY2024.
- Common Equity has a five-year compound annual growth rate of 18.2% (FY2020 to FY2025).
- By fiscal year, Common Equity came in at $74.1 million in FY2024 (-19.0%), $91.43 million in FY2023 (-11.6%), $103.43 million in FY2022 (-22.1%) and $132.78 million in FY2021 (+294.4%).
- Five-year quarterly Common Equity spans a low of $98,300 in fiscal Q3 2023 and a high of $132.78 million in fiscal Q4 2021.
- Year over year, Common Equity has now increased in each of the last four quarters, with an average decline of 2.4% over the last eight quarters.
- The high point for year-over-year Common Equity in five years was fiscal Q1 2022 (growth of 382.8%); the low point was fiscal Q3 2023 (a decline of 99.9%).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $69.08 million (Q2 2026), $93.47 million (Q1 2026) and $77.53 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Citius Pharmaceuticals | 15.10 Mn | 24.39 Mn | 1.00 Mn | 75.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 75.91 Mn |
| Mar 31, 2026 | 69.08 Mn |
| Dec 31, 2025 | 93.47 Mn |
| Sep 30, 2025 | 77.53 Mn |
| Jun 30, 2025 | 67.56 Mn |
| Mar 31, 2025 | 63.58 Mn |
| Dec 31, 2024 | 68.92 Mn |
| Sep 30, 2024 | 74.10 Mn |
| Jun 30, 2024 | 86.28 Mn |
| Mar 31, 2024 | 79.97 Mn |
| Dec 31, 2023 | 85.33 Mn |
| Sep 30, 2023 | 91.43 Mn |
| Jun 30, 2023 | 98,300.17 |
| Mar 31, 2023 | 91.81 Mn |
| Dec 31, 2022 | 101.03 Mn |
| Sep 30, 2022 | 103.43 Mn |
| Jun 30, 2022 | 110.34 Mn |
| Mar 31, 2022 | 118.20 Mn |
| Dec 31, 2021 | 124.56 Mn |
| Sep 30, 2021 | 132.78 Mn |
API Access
Citius Pharmaceuticals Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=CTXR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "CTXR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=CTXR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();